Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Oct 14;58(10):2593-2608.e6.
doi: 10.1016/j.immuni.2025.08.009. Epub 2025 Sep 12.

Multi-scaled transcriptomics of chronically inflamed nasal epithelium reveals immune-epithelial dynamics and tissue remodeling in nasal polyp formation

Affiliations
Free article

Multi-scaled transcriptomics of chronically inflamed nasal epithelium reveals immune-epithelial dynamics and tissue remodeling in nasal polyp formation

Guanrui Liao et al. Immunity. .
Free article

Abstract

Chronic rhinosinusitis (CRS) is a common chronic inflammatory disease of the sinonasal cavity affecting millions worldwide. Its complex pathophysiology remains poorly understood, with emerging evidence implicating interactions between diverse immune and epithelial cells in disease progression. We applied single-cell RNA sequencing (scRNA-seq) and spatial transcriptomics to both dissociated and intact human tissues from individuals with CRS with and without nasal polyps and compared them with controls. We revealed mechanisms of macrophage-eosinophil recruitment, CD4+ and CD8+ T cell dysregulation, and mast cell enrichment. We identified key immune-epithelial interactions in tissue remodeling, particularly involving basal progenitor and tuft cells. A distinct basal cell trajectory was implicated in nasal polyp formation. Orthogonal validation with spatial transcriptomics from >100 individuals with CRS revealed conserved tissue remodeling features. Our study provides insights into CRS pathophysiology, highlighting immune-epithelial interactions as potential therapeutic targets in chronic inflammation, also serving as a resource for dissecting immune disease mechanisms.

Keywords: autoimmunity; chronic rhinosinusitis; inflammation; nasal epithelium; nasal polyp; remodeling; single-cell; spatial transcriptomics; type 2 inflammation.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests S.J. is a co-founder of Elucidate Bio Inc. and serves on its Board of Directors and Scientific Advisory Board and acknowledges research support from Sanofi and Roche unrelated to this work. G.N. is co-founder of IonPath Inc and Akoya Biosciences, Inc.; inventor on patent US9909167; and is a Scientific Advisory Board member for Akoya Biosciences, Inc. V.B. has patents on the programmed cell death 1 (PD-1) pathway licensed by Bristol-Myers Squibb, Roche, Merck, EMD Serono, Boehringer Ingelheim, AstraZeneca, Novartis, and Dako unrelated to this work. J.V.N. is a consultant with Sound Health, C2Dx, Aerin Medical, Acclarent/Integra, and SpirAir, all unrelated to this work.

MeSH terms

LinkOut - more resources